We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,990 hedge funds and large institutions have $267B invested in Johnson & Johnson in 2019 Q4 according to their latest regulatory filings, with 373 funds opening new positions, 1,140 increasing their positions, 1,233 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

465% more first-time investments, than exits

New positions opened: 373 | Existing positions closed: 66

22% more funds holding in top 10

Funds holding in top 10: 485592 (+107)

14% more capital invested

Capital invested by funds: $233B → $267B (+$33.7B)

14% more call options, than puts

Call options by funds: $2.66B | Put options by funds: $2.33B

10% more funds holding

Funds holding: 2,7242,990 (+266)

1.21% more ownership

Funds ownership: 68.38%69.59% (+1.2%)

8% less repeat investments, than reductions

Existing positions increased: 1,140 | Existing positions reduced: 1,233

Holders
2,990
Holders Change
+266
Holders Change %
+9.77%
% of All Funds
58.92%
Holding in Top 10
592
Holding in Top 10 Change
+107
Holding in Top 10 Change %
+22.06%
% of All Funds
11.67%
New
373
Increased
1,140
Reduced
1,233
Closed
66
Calls
$2.66B
Puts
$2.33B
Net Calls
+$334M
Net Calls Change
+$537M
Name Holding Trade Value Shares
Change
Change in
Stake
JCM
426
Janney Capital Management
Pennsylvania
$31.7M -$1.42M -10,451 -5%
SRIM
427
Saratoga Research & Investment Management
California
$31.7M -$17.5K -129 -0.1%
CTA
428
Chesley Taft & Associates
Illinois
$31.5M +$2.31M +17,029 +9%
AC
429
Allstate Corporation
Illinois
$31.4M +$1.05M +7,763 +4%
BAM
430
Berkshire Asset Management
Pennsylvania
$31.3M -$435K -3,206 -1%
BIC
431
Beach Investment Counsel
Pennsylvania
$31.2M -$757K -5,580 -3%
DCM
432
Dupont Capital Management
Delaware
$31.2M +$2.19M +16,156 +8%
AA
433
ALPS Advisors
Colorado
$31.2M -$246K -1,812 -0.8%
Assenagon Asset Management
434
Assenagon Asset Management
Luxembourg
$31.2M -$196M -1,447,750 -87%
CAM
435
Cidel Asset Management
Ontario, Canada
$31.2M +$489K +3,604 +2%
RMA
436
Roffman Miller Associates
Pennsylvania
$31M -$182K -1,341 -0.6%
UB
437
UMB Bank
Missouri
$31M -$295K -2,175 -1%
WG
438
Welch Group
Alabama
$31M +$615K +4,533 +2%
MNBTD
439
Moody National Bank Trust Division
Texas
$30.7M +$144K +1,065 +0.5%
V
440
Veritable
Delaware
$30.3M -$1.07M -7,918 -4%
ACA
441
Anchor Capital Advisors
Massachusetts
$30.1M +$5.01M +36,941 +22%
OSIA
442
O'Shares Investment Advisers
Massachusetts
$30M +$136K +1,001 +0.5%
SCI
443
S&CO Inc
Massachusetts
$30M -$136K -1,004 -0.5%
NMERB
444
New Mexico Educational Retirement Board
New Mexico
$29.9M
OCM
445
Osterweis Capital Management
California
$29.7M +$9.06M +66,819 +49%
QI
446
QS Investors
New York
$29.7M +$1.78M +13,129 +7%
IC
447
InterOcean Capital
Illinois
$29.6M -$1.09M -8,022 -4%
PCIG
448
Partners Capital Investment Group
Massachusetts
$29.3M -$2.32M -17,138 -8%
QAM
449
QCI Asset Management
New York
$29.3M -$1.11M -8,200 -4%
ADEF
450
Adams Diversified Equity Fund
Maryland
$29.2M -$14.1M -104,300 -34%

JNJ Hedge Fund Activity: Q4 2019 in Review

2,990 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2019, worth a combined $267B — up 14% from $233B a quarter earlier.

Buyers outnumbered sellers: 373 funds opened new JNJ positions and 66 closed out — a net gain of 307 holders — while 1,140 added to existing stakes and 1,233 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $783M. The largest seller was Capital World Investors, cutting an estimated $1.27B.

  • 2,990 institutional investors held Johnson & Johnson (JNJ) as of Q4 2019, up from 2,724 in Q3 2019.
  • Funds reported $267B of Johnson & Johnson stock for Q4 2019, up 14% quarter-over-quarter.
  • 373 funds opened new Johnson & Johnson positions in Q4 2019 and 66 closed out, a net change of +307 holders.
  • The largest Johnson & Johnson buyer in Q4 2019 was JP Morgan Chase, an estimated $783M added.
  • The largest Johnson & Johnson seller in Q4 2019 was Capital World Investors, an estimated $1.27B sold.

Based on aggregated 13F filings for Q4 2019.